New molecular approches using AR, FOXA1 and HER2 for outcome classification of estrogen Receptor-Positive (ER+) breast cancers”

Here, we studied new prognostic and predictive easy access strategies in breast cancer (molecular markers), for better classify ER+ breast cancer disease, which might provide additional information and be complementary to the clasical clinical-pathological prediction models.

Grantor dc:publisher

Universidad del Rosario

Year dc:date

2018

Author dc:creator

• Rangel Jiménez, Nelson Enrique

• Breast cancer
• Androgen Receptor
• Estrogen Receptor
• Prognosis
• Molecular medicine
• Enfermedades
• Neoplasias de la mama
• Receptores androgénicos
• Medicina molecular

Statement dc:rights

• info:eu-repo/semantics/openAccess

Licence

• http://creativecommons.org/licenses/by-nc-nd/2.5/co/

Language dc:language

spa

Identifier

http://repository.urosario.edu.co/handle/10336/18932

OAI identifier oai:identifier

oai:repository.urosario.edu.co:10336/18932